Stay updated on DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Sign up to get notified when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.

Latest updates to the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page has been updated to reflect a new version of the study protocol (v2.15.0) and includes a specific EudraCT number for the trial. Additionally, the previous content regarding the survival rates and treatment options for Non-Small Cell Lung Cancer has been removed.SummaryDifference38%
- Check20 days agoChange DetectedThe page has been updated to reflect the latest version as v2.14.4, replacing the previous version v2.14.3. The estimated last update posted has been removed.SummaryDifference0.1%
- Check27 days agoChange DetectedThe web page has been updated to reflect a new software version, changing from v2.14.2 to v2.14.3. Additionally, the product is now indicated as not being manufactured in and exported from the U.S.SummaryDifference0.4%
- Check56 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check78 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check85 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.